Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Hologic Inc (HOLX) since 2006 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Hologic Inc. (See page 1 of this report.) Table 2 shows the detailed insider transactions. This company's CIK number is 859737.
Total stock buying since 2006: $12,244,759.
Total stock sales since 2006: $634,825,850.
Total stock option exercises since 2006: $159,732,670.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2025 | 5,445 | $300,760 | 0 | $0 | 0 | $0 |
| 2024 | 0 | $0 | 85,021 | $6,531,480 | 61,093 | $2,390,035 |
| 2023 | 0 | $0 | 86,729 | $6,360,996 | 56,839 | $1,624,479 |
| 2022 | 0 | $0 | 95,152 | $7,208,083 | 75,268 | $3,063,376 |
| 2021 | 0 | $0 | 52,750 | $4,080,776 | 40,079 | $1,528,052 |
| 2020 | 0 | $0 | 588,098 | $32,171,174 | 640,144 | $15,453,293 |
| 2019 | 0 | $0 | 445,566 | $21,146,042 | 482,355 | $10,630,524 |
| 2018 | 24,800 | $954,245 | 117,125 | $4,815,729 | 153,020 | $1,605,390 |
| 2017 | 0 | $0 | 288,613 | $12,275,775 | 1,264,869 | $10,224,820 |
| 2016 | 0 | $0 | 142,483 | $5,376,337 | 695,535 | $3,580,480 |
| 2015 | 0 | $0 | 6,478,040 | $261,377,816 | 784,479 | $16,968,532 |
| 2014 | 246,195 | $5,187,797 | 508,074 | $11,710,696 | 608,732 | $10,140,717 |
| 2013 | 0 | $0 | 721,384 | $15,767,950 | 691,566 | $6,338,665 |
| 2012 | 0 | $0 | 671,295 | $13,318,481 | 648,806 | $4,901,686 |
| 2011 | 0 | $0 | 1,109,135 | $22,934,215 | 512,871 | $5,091,350 |
| 2010 | 0 | $0 | 48,420 | $812,180 | 26,953 | $372,668 |
| 2009 | 7,500 | $92,571 | 542,500 | $8,297,005 | 672,500 | $3,253,657 |
| 2008 | 282,005 | $5,705,164 | 62,960 | $4,398,669 | 115,792 | $2,084,577 |
| 2007 | 67 | $4,222 | 2,840,654 | $175,681,533 | 2,706,780 | $57,736,860 |
| 2006 | 0 | $0 | 423,000 | $20,560,913 | 427,000 | $2,743,509 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2013-10-15 | Muir Glenn P (Executive VP and CFO) | Option Ex | 28,000 | 3.56 | 99,764 |
| 2013-09-16 | Muir Glenn P (Executive VP and CFO) | Sale | 28,000 | 20.45 | 572,600 |
| 2013-09-16 | Muir Glenn P (Executive VP and CFO) | Option Ex | 28,000 | 3.56 | 99,764 |
| 2013-09-13 | Lavallee Robert H (SVP, Chief Accounting Officer) | Sale | 2,500 | 20.33 | 50,824 |
| 2013-09-13 | Lavallee Robert H (SVP, Chief Accounting Officer) | Option Ex | 2,500 | 3.56 | 8,907 |
| 2013-08-20 | Brady David J (SVP, Human Resources) | Sale | 42,328 | 22.80 | 965,290 |
| 2013-08-20 | Brady David J (SVP, Human Resources) | Option Ex | 32,000 | 14.50 | 464,000 |
| 2013-08-15 | Muir Glenn P (Executive VP and CFO) | Sale | 28,000 | 22.49 | 629,720 |
| 2013-08-15 | Muir Glenn P (Executive VP and CFO) | Option Ex | 28,000 | 3.56 | 99,764 |
| 2013-08-08 | Casey Mark J (SVP, CAO & General Counsel) | Sale | 14,804 | 22.57 | 334,126 |
| 2013-08-08 | Levy Lawrence M (Director) | Sale | 5,000 | 22.50 | 112,500 |
| 2013-08-06 | Hastie Rohan (Group VP & GM, Diagnostics) | Option Ex | 1,272 | 22.58 | 28,721 |
| 2013-07-19 | Lavallee Robert H (SVP, Chief Accounting Officer) | Sale | 11,254 | 20.89 | 235,096 |
| 2013-07-15 | Muir Glenn P (Executive VP and CFO) | Sale | 28,000 | 19.78 | 553,840 |
| 2013-07-15 | Muir Glenn P (Executive VP and CFO) | Option Ex | 28,000 | 3.56 | 99,764 |
| 2013-07-01 | Cascella Robert (CEO and President) | Sale | 20,000 | 19.55 | 391,000 |
| 2013-07-01 | Cascella Robert (CEO and President) | Option Ex | 20,000 | 3.56 | 71,260 |
| 2013-06-17 | Muir Glenn P (Executive VP and CFO) | Sale | 28,000 | 21.42 | 599,760 |
| 2013-06-17 | Muir Glenn P (Executive VP and CFO) | Option Ex | 28,000 | 3.56 | 99,764 |
| 2013-06-03 | Cascella Robert (CEO and President) | Sale | 20,000 | 20.71 | 414,200 |
| 2013-06-03 | Cascella Robert (CEO and President) | Option Ex | 20,000 | 3.56 | 71,260 |
| 2013-03-11 | Lavance David R Jr (Director) | Sale | 17,771 | 22.12 | 393,094 |
| 2013-03-11 | Lavance David R Jr (Director) | Option Ex | 12,774 | 18.82 | 240,406 |
| 2013-02-27 | Soltani Peter (SVP & GM, Women's Health) | Sale | 88,729 | 22.04 | 1,955,853 |
| 2013-02-27 | Soltani Peter (SVP & GM, Women's Health) | Option Ex | 88,729 | 14.44 | 1,280,891 |
| 2013-02-25 | Levy Lawrence M (Director) | Sale | 5,000 | 22.00 | 110,000 |
| 2013-02-21 | Soltani Peter (SVP & GM, Women's Health) | Sale | 4,826 | 21.29 | 102,745 |
| 2013-02-14 | Brady David J (SVP, Human Resources) | Sale | 20,000 | 22.20 | 444,000 |
| 2013-02-14 | Brady David J (SVP, Human Resources) | Option Ex | 20,000 | 13.87 | 277,300 |
| 2013-02-01 | Cascella Robert (CEO and President) | Sale | 21,984 | 23.50 | 516,514 |
| 2013-02-01 | Cascella Robert (CEO and President) | Option Ex | 21,984 | 1.92 | 42,209 |
| 2013-01-09 | Casey Mark J (SVP, CAO & General Counsel) | Sale | 129,526 | 22.04 | 2,854,753 |
| 2013-01-09 | Casey Mark J (SVP, CAO & General Counsel) | Option Ex | 124,602 | 15.83 | 1,972,075 |
| 2013-01-02 | Cascella Robert (CEO and President) | Sale | 21,985 | 20.39 | 448,384 |
| 2013-01-02 | Cascella Robert (CEO and President) | Option Ex | 21,985 | 1.92 | 42,211 |
| 2012-12-14 | Lavallee Robert H (SVP, Chief Accounting Officer) | Sale | 14,281 | 19.88 | 283,906 |
| 2012-12-13 | Wilson Wayne (Director) | Sale | 22,878 | 19.76 | 452,069 |
| 2012-12-13 | Wilson Wayne (Director) | Option Ex | 24,604 | 18.32 | 450,745 |
| 2012-12-03 | Cascella Robert (CEO and President) | Sale | 21,656 | 18.85 | 408,215 |
| 2012-12-03 | Cascella Robert (CEO and President) | Option Ex | 21,656 | 1.92 | 41,579 |
| 2012-11-15 | Stein Jay A (Chief Technical Officer) | Sale | 55,980 | 19.52 | 1,093,009 |
| 2012-11-15 | Stein Jay A (Chief Technical Officer) | Option Ex | 40,000 | 3.56 | 142,520 |
| 2012-11-01 | Cascella Robert (CEO and President) | Sale | 21,875 | 21.01 | 459,593 |
| 2012-11-01 | Cascella Robert (CEO and President) | Option Ex | 21,875 | 1.92 | 42,000 |
| 2012-09-14 | Brady David J (SVP, Human Resources) | Sale | 15,000 | 20.66 | 309,900 |
| 2012-09-14 | Brady David J (SVP, Human Resources) | Option Ex | 15,000 | 15.75 | 236,250 |
| 2012-09-12 | Muir Glenn P (Executive VP and CFO) | Sale | 42,900 | 19.84 | 851,350 |
| 2012-09-12 | Muir Glenn P (Executive VP and CFO) | Option Ex | 68,750 | 2.38 | 163,281 |
| 2012-09-07 | Harding David (SVP, International) | Sale | 7,800 | 20.15 | 157,170 |
| 2012-09-07 | Harding David (SVP, International) | Option Ex | 7,800 | 18.32 | 142,896 |
| 2012-09-06 | Harding David (SVP, International) | Sale | 63,220 | 20.17 | 1,275,147 |
| 2012-09-06 | Harding David (SVP, International) | Option Ex | 46,020 | 18.32 | 843,086 |
| 2012-09-05 | Muir Glenn P (Executive VP and CFO) | Sale | 68,750 | 19.96 | 1,372,250 |
| 2012-09-05 | Muir Glenn P (Executive VP and CFO) | Option Ex | 68,750 | 2.38 | 163,281 |
| 2012-08-22 | Muir Glenn P (Executive VP and CFO) | Sale | 68,750 | 19.66 | 1,351,625 |
| 2012-08-22 | Muir Glenn P (Executive VP and CFO) | Option Ex | 68,750 | 2.38 | 163,281 |
| 2012-08-08 | Muir Glenn P (Executive VP and CFO) | Sale | 68,750 | 19.69 | 1,353,687 |
| 2012-08-08 | Muir Glenn P (Executive VP and CFO) | Option Ex | 68,750 | 2.38 | 163,281 |
| 2012-08-07 | Soltani Peter (SVP, Breast Health) | Sale | 418 | 19.99 | 8,355 |
| 2012-08-06 | Crawford Sally (Director) | Sale | 24,604 | 19.70 | 484,698 |
| 2012-08-06 | Crawford Sally (Director) | Option Ex | 24,604 | 18.32 | 450,745 |
| 2012-08-06 | Soltani Peter (SVP, Breast Health) | Sale | 8,017 | 19.69 | 157,854 |
| 2012-06-08 | Casey Mark J (SVP, General Counsel) | Sale | 3,985 | 16.79 | 66,908 |
| 2012-05-08 | Cascella Robert (CEO and President) | Option Ex | 25,000 | 1.92 | 48,000 |
| 2012-05-08 | Muir Glenn P (Executive VP and CFO) | Option Ex | 25,000 | 2.38 | 59,375 |
| 2012-05-02 | Cascella Robert (CEO and President) | Sale | 12,500 | 18.53 | 231,625 |
| 2012-05-02 | Cascella Robert (CEO and President) | Option Ex | 12,500 | 1.92 | 24,000 |
| 2012-03-08 | Lavance David R Jr (Director) | Sale | 4,649 | 20.75 | 96,466 |
| 2012-03-07 | Williamson Steve S (SVP, GYN Surgical) | Sale | 3,649 | 20.31 | 74,111 |
| 2012-03-02 | Cascella Robert (CEO and President) | Sale | 12,500 | 20.87 | 260,875 |
| 2012-03-02 | Cascella Robert (CEO and President) | Option Ex | 12,500 | 1.92 | 24,000 |
| 2012-02-16 | Lavallee Robert H (SVP, Chief Accounting Officer) | Sale | 9,381 | 21.00 | 197,001 |
| 2012-02-10 | Levy Lawrence M (Director) | Sale | 5,000 | 20.70 | 103,524 |
| 2012-02-10 | Crawford Sally (Director) | Sale | 30,000 | 20.52 | 615,600 |
| 2012-02-03 | Brady David J (SVP, Human Resources) | Sale | 27,421 | 21.11 | 578,775 |
| 2012-02-03 | Brady David J (SVP, Human Resources) | Option Ex | 19,961 | 15.85 | 316,282 |
| 2012-02-03 | Ullian Elaine (Director) | Sale | 4,649 | 20.71 | 96,280 |
| 2012-01-12 | Crawford Sally (Director) | Option Ex | 24,604 | 18.46 | 454,312 |
| 2012-01-10 | Casey Mark J (SVP, General Counsel) | Sale | 10,416 | 18.75 | 195,300 |
| 2012-01-10 | Casey Mark J (SVP, General Counsel) | Option Ex | 10,416 | 18.46 | 192,331 |
| 2012-01-06 | Harding David (SVP, International) | Sale | 42,266 | 18.53 | 783,188 |
| 2012-01-06 | Harding David (SVP, International) | Option Ex | 42,266 | 18.46 | 780,441 |
| 2011-11-10 | Muir Glenn P (Executive VP and CFO) | Sale | 100,000 | 17.09 | 1,709,100 |
| 2011-11-10 | Muir Glenn P (Executive VP and CFO) | Option Ex | 100,000 | 2.56 | 256,500 |
| 2011-11-07 | Muir Glenn P (Executive VP and CFO) | Option Ex | 50,000 | 2.56 | 128,250 |
| 2011-10-07 | Muir Glenn P (Executive VP and CFO) | Option Ex | 50,000 | 2.56 | 128,250 |
| 2011-05-23 | Stein Jay A (Chief Technical Officer) | Sale | 400,000 | 20.76 | 8,304,000 |
| 2011-05-09 | Harding David (SVP, International) | Sale | 159,308 | 22.41 | 3,569,614 |
| 2011-05-09 | Harding David (SVP, International) | Option Ex | 159,308 | 16.46 | 2,621,891 |
| 2011-03-11 | Lavallee Robert H (SVP, Chief Accounting Officer) | Sale | 7,219 | 21.48 | 155,028 |
| 2011-03-11 | Lavallee Robert H (SVP, Chief Accounting Officer) | Option Ex | 5,000 | 3.56 | 17,815 |
| 2011-03-08 | Casey Mark J (SVP, General Counsel) | Sale | 6,610 | 21.27 | 140,594 |
| 2011-03-08 | Cumming John W (Chairman) | Sale | 70,449 | 21.37 | 1,505,495 |
| 2011-03-07 | Lavance David R Jr (Director) | Sale | 16,071 | 21.00 | 337,491 |
| 2011-03-07 | Lavance David R Jr (Director) | Option Ex | 16,071 | 14.50 | 233,029 |
| 2011-03-07 | Cumming John W (Chairman) | Sale | 12,100 | 21.26 | 257,246 |
| 2011-03-04 | Crawford Sally (Director) | Sale | 6,694 | 20.92 | 140,038 |
| 2011-03-03 | Cumming John W (Chairman) | Sale | 50,000 | 21.25 | 1,062,500 |
| 2011-02-23 | Soltani Peter (SVP, Breast Health) | Sale | 16,528 | 19.84 | 327,915 |
| 2011-02-18 | Lavance David R Jr (Director) | Sale | 6,034 | 20.63 | 124,481 |
| 2011-02-16 | Williamson Steve S (SVP, GYN Surgical) | Sale | 1,707 | 20.26 | 34,583 |
| 2011-02-15 | Williamson Steve S (SVP, GYN Surgical) | Sale | 16,800 | 19.95 | 335,244 |
| 2011-02-15 | Williamson Steve S (SVP, GYN Surgical) | Option Ex | 16,800 | 14.30 | 240,240 |
| 2011-02-11 | Williamson Steve S (SVP, GYN Surgical) | Sale | 3,880 | 19.58 | 75,982 |
| 2011-02-11 | Crawford Sally (Director) | Sale | 13,000 | 19.89 | 258,635 |
| 2011-02-09 | Williamson Steve S (SVP, GYN Surgical) | Sale | 5,766 | 19.49 | 112,379 |
| 2011-02-09 | Williamson Steve S (SVP, GYN Surgical) | Option Ex | 5,766 | 14.24 | 82,136 |
| 2011-02-09 | Casey Mark J (SVP, General Counsel) | Sale | 7,020 | 19.50 | 136,890 |
| 2011-02-09 | Casey Mark J (SVP, General Counsel) | Option Ex | 7,020 | 15.81 | 110,986 |
| 2011-02-08 | Wilson Wayne (Director) | Sale | 9,949 | 19.60 | 195,000 |
| 2011-02-08 | Wilson Wayne (Director) | Option Ex | 12,302 | 15.81 | 194,494 |
| 2011-02-03 | Leaming Nancy (Director) | Option Ex | 20,000 | 3.40 | 68,000 |
| 2011-01-18 | Crawford Sally (Director) | Option Ex | 24,604 | 15.81 | 388,989 |
| 2011-01-03 | Crawford Sally (Director) | Option Ex | 46,000 | 13.49 | 620,770 |
| 2010-11-24 | Williamson Steve S (SVP, GYN Surgical) | Sale | 2,762 | 16.76 | 46,299 |
| 2010-11-24 | Casey Mark J (SVP, General Counsel) | Sale | 3,098 | 16.80 | 52,046 |
| 2010-03-12 | Doran Howard Jr (SVP, Diagnostics Products) | Sale | 7,688 | 18.50 | 142,228 |
| 2010-03-12 | Doran Howard Jr (SVP, Diagnostics Products) | Option Ex | 7,688 | 15.81 | 121,547 |
| 2010-02-26 | Casey Mark J (SVP, General Counsel) | Sale | 2,219 | 17.10 | 37,949 |
| 2010-02-04 | Levy Lawrence M (Director) | Sale | 6,694 | 16.36 | 109,513 |
| 2010-02-04 | Lavance David R Jr (Director) | Sale | 24,575 | 16.33 | 401,309 |
| 2010-02-04 | Lavance David R Jr (Director) | Option Ex | 17,881 | 13.07 | 233,704 |
| 2010-02-03 | Williamson Steve S (SVP, GYN Surgical) | Sale | 1,384 | 16.50 | 22,836 |
| 2010-02-03 | Williamson Steve S (SVP, GYN Surgical) | Option Ex | 1,384 | 12.59 | 17,417 |
| 2009-11-02 | Muir Glenn P (Executive VP and CFO) | Sale | 70,000 | 14.80 | 1,036,280 |
| 2009-11-02 | Muir Glenn P (Executive VP and CFO) | Option Ex | 70,000 | 5.09 | 356,090 |
| 2009-10-30 | Muir Glenn P (Executive VP and CFO) | Option Ex | 70,000 | 5.09 | 356,090 |
| 2009-09-21 | Muir Glenn P (Executive VP and CFO) | Option Ex | 50,000 | 4.75 | 237,500 |
| 2009-08-31 | Stein Jay A (Chief Technical Officer) | Option Ex | 10,000 | 2.38 | 23,750 |
| 2009-08-26 | Lavallee Robert H (SVP, Chief Accounting Officer) | Sale | 17,500 | 16.19 | 283,325 |
| 2009-08-26 | Lavallee Robert H (SVP, Chief Accounting Officer) | Option Ex | 17,500 | 5.09 | 89,022 |
| 2009-08-20 | Brady David J (SVP, Human Resources) | Sale | 25,000 | 15.68 | 392,100 |
| 2009-08-20 | Brady David J (SVP, Human Resources) | Option Ex | 25,000 | 3.56 | 89,075 |
| 2009-08-19 | Cumming John W (Chairman & CEO) | Sale | 265,000 | 15.67 | 4,152,020 |
| 2009-08-19 | Cumming John W (Chairman & CEO) | Option Ex | 265,000 | 5.09 | 1,348,055 |
| 2009-08-14 | Cascella Robert (President & COO) | Sale | 140,000 | 14.83 | 2,075,780 |
| 2009-08-14 | Cascella Robert (President & COO) | Option Ex | 140,000 | 4.75 | 665,000 |
| 2009-08-06 | Brady David J (SVP, Human Resources) | Sale | 25,000 | 14.30 | 357,500 |
| 2009-08-06 | Brady David J (SVP, Human Resources) | Option Ex | 25,000 | 3.56 | 89,075 |
| 2009-05-19 | Doran Howard Jr (SVP, Diagnostics Products) | Buy | 3,500 | 11.97 | 41,891 |
| 2009-05-05 | Soltani Peter (SVP, Breast Health) | Buy | 4,000 | 12.67 | 50,680 |
| 2008-08-07 | Cascella Robert (President & COO) | Buy | 24,600 | 20.20 | 496,920 |
| 2008-08-07 | Muir Glenn P (Executive VP & CFO) | Buy | 50,000 | 19.80 | 990,000 |
| 2008-08-07 | Cumming John W (Chairman & CEO) | Buy | 100,000 | 20.03 | 2,003,098 |
| 2008-08-04 | Doran Howard Jr (President, Diagnostics) | Buy | 100 | 18.26 | 1,826 |
| 2008-06-13 | Mcdaniel C William (Director) | Buy | 20,000 | 23.40 | 468,000 |
| 2008-05-01 | Muir Glenn P (Executive VP & CFO) | Option Ex | 16,832 | 1.45 | 24,322 |
| 2008-02-06 | Muir Glenn P (Executive VP and CFO) | Sale | 5,000 | 64.06 | 320,300 |
| 2008-02-06 | Muir Glenn P (Executive VP and CFO) | Option Ex | 5,000 | 9.50 | 47,500 |
| 2008-01-31 | Wilson Wayne (Director) | Buy | 5 | 62.32 | 311 |
Insider trading activities including stock purchases, stock sales, and option exercises of HOLX listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Hologic Inc (symbol HOLX, CIK number 859737) see the Securities and Exchange Commission (SEC) website.